A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers by Gan, Hui K., Parakh, Sagun, Lee, F. T., Tebbutt, Niall C., Ameratunga, Malaka, Lee, Sze Ting, O’Keefe, Graeme J., Gong, Sylvia J., Vanrenen, Christine, Caine, Jaren, Giovannetti, Mara, Murone, Carmel, Scott, Fiona E., Guo, Nancy, Burvenich, Ingrid J. G., Paine, Cameron, Macri, Mary J., Kotsuma, Masakatsu, Senaldi, Giorgio, Venhaus, Ralph, Scott, Andrew M.

Get full text